Out-of-pocket expenditure on community healthcare services at end-of-life among decedents from cardiovascular disease in six European countries and Israel.
Cardiovascular disease
Economic capacity
Out-of-pocket
SHARE
Welfare regime
Journal
Health economics review
ISSN: 2191-1991
Titre abrégé: Health Econ Rev
Pays: Germany
ID NLM: 101583209
Informations de publication
Date de publication:
13 Jun 2023
13 Jun 2023
Historique:
received:
16
06
2022
accepted:
02
06
2023
medline:
13
6
2023
pubmed:
13
6
2023
entrez:
13
6
2023
Statut:
epublish
Résumé
Most people who develop chronic diseases, including cardiovascular disease (CVD), live in their homes in the community in their last year of life. Since cost-sharing is common in most countries, including those with universal health insurance, these people incur out of pocket expenditure (OOPE). The study aims to identify the prevalence and measure the size of OOPE among CVD decedents at end-of-life (EOL) explore differences among countries in OOPE, and examine whether the decedents' characteristics or their countries' health policy affects OOPE more. SHARE data among people aged 50 + from seven European countries (including Israel) who died from CVD are analyzed. Decedents' family members are interviewed to learn about OOPE on their relatives' account. We identified 1,335 individuals who had died from CVD (average age 80.8 years, 54% men). More than half of CVD-decedent people spend OOPE on community services at EOL and their expenditure varies widely among countries. About one-third of people in France and Spain had OOPE, rising to around two-thirds in Israel and Italy and almost all in Greece. The average OOPE is 391.9 PPT, with wide variance across countries. Significant odds of OOPE exist in the country variable only, and significant differences exist in the amount of OOPE among countries and duration of illness preceding death. Since improving CVD care efficiency and effectiveness are key aims, healthcare policymakers should broaden the investigation into expanding public funding for community services in order to mitigate OOPE, alleviate the economic burden on households, mitigate forgoing of community services due to price, and reduce rehospitalization.
Identifiants
pubmed: 37310544
doi: 10.1186/s13561-023-00449-4
pii: 10.1186/s13561-023-00449-4
pmc: PMC10262447
doi:
Types de publication
Journal Article
Langues
eng
Pagination
37Informations de copyright
© 2023. The Author(s).
Références
Int J Cardiol. 2022 Jun 1;356:19-29
pubmed: 36047632
Pharmacoeconomics. 2020 Nov;38(11):1219-1236
pubmed: 32812149
Health Aff (Millwood). 2008 Sep-Oct;27(5):1315-27
pubmed: 18780917
Can J Cardiol. 2006 Jul;22(9):749-54
pubmed: 16835668
Eur J Prev Cardiol. 2018 Jun;25(9):985-993
pubmed: 29664673
Eur J Prev Cardiol. 2021 May 8;28(4):400-407
pubmed: 33966082
N Engl J Med. 2008 Mar 6;358(10):1064-71
pubmed: 18322289
Circ Heart Fail. 2013 May;6(3):606-19
pubmed: 23616602
Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):599-606
pubmed: 20562629
JAMA. 2010 May 5;303(17):1716-22
pubmed: 20442387
Eur J Clin Pharmacol. 2013 Aug;69(8):1553-63
pubmed: 23588558
Heart Fail Rev. 2018 Jan;23(1):131-145
pubmed: 29124528
Int J Cardiol. 2016 Sep 15;219:70-8
pubmed: 27288969
Am Heart J. 2009 Apr;157(4):709-15.e1
pubmed: 19332200
J Am Coll Cardiol. 2014 Apr 1;63(12):1123-1133
pubmed: 24491689
Eur J Prev Cardiol. 2020 May;27(7):749-757
pubmed: 31180761
BMC Palliat Care. 2013 Feb 15;12:7
pubmed: 23414145
J Am Geriatr Soc. 2000 Dec;48(12):1646-54
pubmed: 11129756
Circulation. 2015 Sep 1;132(9):873-98
pubmed: 26240271
CMAJ. 2005 Jan 18;172(2):189-94
pubmed: 15655239
BMC Cardiovasc Disord. 2014 Sep 24;14:127
pubmed: 25252927
Soc Sci Med. 2006 Oct;63(7):1720-31
pubmed: 16781037
J Clin Pharm Ther. 2012 Feb;37(1):37-44
pubmed: 21294760
Value Health. 2017 Jan;20(1):67-76
pubmed: 28212972
BMC Health Serv Res. 2011 Aug 30;11:207
pubmed: 21878111
JAMA. 2004 Jan 7;291(1):88-93
pubmed: 14709580
JAMA. 2016 Jan 19;315(3):272-83
pubmed: 26784775
Palliat Med. 2017 Jan;31(1):42-52
pubmed: 27129681
Health Aff (Millwood). 2017 Jul 1;36(7):1201-1210
pubmed: 28679806
JAMA. 2013 Jan 23;309(4):355-63
pubmed: 23340637